Indian Ceftriaxone Exporters: Complete Supplier Ranking with Market Share — 2555 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ceftriaxone buyer importing from India?

ROYAL PHARMA 2011 LIMITED (KENYA) is the largest ceftriaxone importer from India with a 10.4% market share and import value of $29.8M.

Q: How many ceftriaxone buyers import from India?

There are 2555 active ceftriaxone buyers importing from India, with a combined import market of $285.4M across 11,257 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ceftriaxone buyers from India?

The top 5 ceftriaxone buyers — ROYAL PHARMA 2011 LIMITED, SAAM GROUP LTD, PHARMACIE CENTRALE GUINEE, SEA GOLD PHARMA, AUROVIDA FARMACEUTICA, SA DE CV, — together control 27.2% of total ceftriaxone import value from India.

Suresh Sormare

Ceftriaxone

India Pharmaceutical Trade Intelligence

$285.4M850 Suppliers162 CountriesHS 30042019

ExportsIndia → KENYA17.7%India → AFGHANISTAN7.3%

ImportsIRAQ → India$50.2K UNITED ARAB → India$41.4K

#1 Supplier: INNOVA CAPTAB #1 Buyer: ROYAL PHARMA

Market Analysis: Top Importing Countries & Their Importers

1Kenya

Kenya emerges as the first largest importing country, achieving a total trade value of $50.6M through 135 shipments. This represents a market share of 17.7% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Kenya has a diverse importer base, with their top importers including:

• ROYAL PHARMA 2011 LIMITED - $29.8M (59.0% of country's total business)

Key Insight: Kenya demonstrates strong market positioning with an average shipment value of $374.5K, indicating premium pricing strategy compared to the market average of $25.4K.

Kenya is a key market for Ceftriaxone imports, representing 17.7% of total trade value.

Primary Market

Secondary Market

2Afghanistan

Afghanistan emerges as the second largest importing country, achieving a total trade value of $20.9M through 15 shipments. This represents a market share of 7.3% of the total market activity, demonstrating their significant presence in the industry.

Buyer Segment Analysis

TransData Nexus Ceftriaxone buyer market intelligence

1Buyer Segment Analysis

The 2,555 buyers of Ceftriaxone from India can be categorized into several segments:

1. Distributors: Entities like SAAM GROUP LTD in Pakistan and SEA GOLD PHARMA in Turkey function as intermediaries, purchasing large volumes to supply regional markets. Their buying behavior is characterized by bulk orders to achieve economies of scale, with a focus on maintaining consistent supply chains.

2. Government Procurement Agencies: Organizations such as PHARMACIE CENTRALE GUINEE in Guinea and TO THE DIRECTOR OF in Sudan are likely involved in national healthcare procurement. They typically engage in tender-based purchasing, emphasizing cost-effectiveness and compliance with national health policies.

3. Hospital Groups: Entities like ROYAL PHARMA 2011 LIMITED in Kenya and KHAN SEHAT LTD in Afghanistan may represent hospital networks or large healthcare providers. Their procurement patterns often involve regular, sizable orders to meet the consistent demand within healthcare facilities.

4. Retail Chains: Companies such as AUROVIDA FARMACEUTICA, SA DE CV in Mexico and EUGIA PHARMA INDUSTRIA FARMACEUTICA in Brazil likely operate extensive pharmacy networks. They procure Ceftriaxone to stock their outlets, ensuring availability for outpatient treatments, with purchasing patterns influenced by consumer demand and inventory turnover rates.

5. Re-exporters: Firms like AL JABAL DRUGS & MEDICAL APPLIANCES in Yemen may act as re-exporters, importing Ceftriaxone for redistribution to neighboring regions. Their buying behavior is driven by regional demand fluctuations and trade agreements.

6. Contract Manufacturers: Entities such as M/S. PRINCE PHARMA DEPOT PHARMACETI in the Democratic Republic of Congo might engage in contract manufacturing, importing raw Ceftriaxone for local formulation and packaging. Their procurement is typically aligned with production schedules and contractual obligations.

Country-Specific Import Regulations

TransData Nexus Ceftriaxone buyer market intelligence

1Country-Specific Import Regulations

Kenya:

1Drug Regulatory Authority: Pharmacy and Poisons Board (PPB).
2Import Registration Process: Importers must register pharmaceutical products with the PPB, providing comprehensive documentation, including product dossiers and evidence of Good Manufacturing Practice (GMP) compliance.
3Estimated Timeline for Registration: Approximately 6 to 12 months, depending on the completeness of the application and regulatory reviews.
4Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are typically exempt from import duties, aligning with Kenya's commitment to affordable healthcare.

Afghanistan:

Demand Drivers & Market Opportunity

TransData Nexus Ceftriaxone buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ceftriaxone in importing countries is driven by several factors:

1. Disease Prevalence: High incidences of bacterial infections such as pneumonia, meningitis, and typhoid fever necessitate the use of broad-spectrum antibiotics like Ceftriaxone. For instance, a study in Ethiopia highlighted inappropriate Ceftriaxone use for conditions like typhoid fever and pneumonia, indicating its widespread application in treating these diseases.

2. Government Healthcare Programs: Many countries have national health initiatives aimed at combating infectious diseases, leading to bulk procurement of essential antibiotics.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the accessibility of essential medicines, boosting demand for antibiotics.

4. WHO Essential Medicines List Procurement: Ceftriaxone's inclusion in the WHO Model List of Essential Medicines underscores its critical role in healthcare, prompting countries to prioritize its procurement.

5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure medicines, ensuring competitive pricing and consistent supply.

With 2,555 buyers across 162 countries, the global market for Ceftriaxone presents substantial opportunities. Understanding the specific demand drivers and regulatory landscapes in each importing country is crucial for strategic market engagement and sustained growth.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Ceftriaxone Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest ceftriaxone buyer importing from India?

Based on import volume and value, ROYAL PHARMA 2011 LIMITED (KENYA) leads with $29.8M in imports and a 10.4% market share — the highest of any single ceftriaxone importer. SAAM GROUP LTD (PAKISTAN) and PHARMACIE CENTRALE GUINEE (GUINEA) are the next largest buyers.

QHow many companies buy ceftriaxone from India?

There are 2555 active ceftriaxone buyers importing from India, with a combined market of $285.4M across 11,257 shipments to 162 countries. The top 5 buyers hold 27.2% of total import value, while the remaining 2550 buyers handle the other 72.8%.

QWhich countries import the most ceftriaxone from India?

The top importing countries for ceftriaxone from India are Kenya (17.7%), Afghanistan (7.3%), Mexico (5.9%), Guinea (5.0%), Ethiopia (4.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of ceftriaxone, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for ceftriaxone from India?

The average import transaction value for ceftriaxone from India is $25.4K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Ceftriaxone buyer market intelligence

1Buyer Segment Analysis

The 2,555 buyers of Ceftriaxone from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Ceftriaxone buyer market intelligence

1Country-Specific Import Regulations

Kenya:

1Drug Regulatory Authority: Pharmacy and Poisons Board (PPB).
2Import Registration Process: Importers must register pharmaceutical products with the PPB, providing comprehensive documentation, including product dossiers and evidence of Good Manufacturing Practice (GMP) compliance.
3Estimated Timeline for Registration: Approximately 6 to 12 months, depending on the completeness of the application and regulatory reviews.
4Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are typically exempt from import duties, aligning with Kenya's commitment to affordable healthcare.

Afghanistan:

Demand Drivers & Market Opportunity

TransData Nexus Ceftriaxone buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ceftriaxone in importing countries is driven by several factors:

2. Government Healthcare Programs: Many countries have national health initiatives aimed at combating infectious diseases, leading to bulk procurement of essential antibiotics.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage increase the accessibility of essential medicines, boosting demand for antibiotics.

5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure medicines, ensuring competitive pricing and consistent supply.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ceftriaxone

Ceftriaxone

Who Buys Ceftriaxone from India — 2555 Importers Behind a $285.4M Market

Top Ceftriaxone Importers — Ranked by Import Value

Top Ceftriaxone Buyers & Importers

Related Analysis

Need Details?

Ceftriaxone — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Ceftriaxone — and from which countries?

Ceftriaxone — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Kenya

2Afghanistan

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Ceftriaxone Buyers & Importers

QWho is the largest ceftriaxone buyer importing from India?

QHow many companies buy ceftriaxone from India?

QWhich countries import the most ceftriaxone from India?

QWhat is the average import order value for ceftriaxone from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Mexico

4Guinea

5Ethiopia

Analysis Methodology